Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good to see this too:
"We will have a definitive answer on September 7th, 2010, and we will report the results of the warrant exercise shortly thereafter."
Good to see this too:
"We will have a definitive answer on September 7th, 2010, and we will report the results of the warrant exercise shortly thereafter."
I like this one also:
We expect to choose our partner for the development and commercialization of this new molecular diagnostic test for pancreatic cancer in the very near future.
I like this one also:
We expect to choose our partner for the development and commercialization of this new molecular diagnostic test for pancreatic cancer in the very near future.
I like this statement about choice:
We expect to choose our partner/partners for the development and commercialization of this new molecular diagnostic test for colon cancer in the very near future.
Maybe they are keeping a low profile until the warrant issue is resolved.
Could this be the reason for the spike in volume?
http://finance.yahoo.com/news/Emerging-Stock-Report-pz-1844807528.html?x=0&.v=1
Sorry, but things are going to have to get really good before I can say that we're out from under this SCREW-UP which has cost us almost $2 Million, significant dilution and the promise of more pain in the future.
Exercising warrants and buying shares in the open market are two completely different things.
When you exercise a warrant you basically send the company the cost of the exercise price and the company would instruct the transfer agent to issue shares from the treasury (a private transaction).
Starting to see a little green colored volume;)
Any reason for the "Non Disclosure"?
Quest Diagnostics to Speak at the William Blair & Company 30th Annual Growth Stock Conference (What will they say????)
MADISON, N.J., June 9, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the William Blair & Company 30th Annual Growth Stock Conference in Chicago. The presentation is scheduled for Tuesday, June 15, 2010 at 10:10 a.m. Central Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.wsw.com/webcast/blair36/dgx/ and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available immediately following the conclusion of the live event and will remain available until July 15, 2010.
Don't think a RS is in the cards. I think they want to get the warrants exercised and I believe the latest filing is an indication that they are preparing for it to happen.
"We anticipate a limited beta release of the iPhone application around Memorial Day, 2010."
Men's Skin Cancer Deaths Double In Last 30 Years
http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=190402
YAFI, Since you claim to have such a large position in HDVY, are you aware of the significance of this filing:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 NOTICE OF EFFECTIVENESS
Effective Date: May 26, 2010
Accession Number: 0001188112-10-001437
Submission Type: POS AM
CIK: 0001141788
Company Name: HEALTH DISCOVERY CORP
File Number: 333-150878
Is HDC getting ready for something?
POST-EFFECTIVE AMENDMENT NO. 2 to FORM S-1
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ?
Subject to Completion, dated April 30, 2010
PROSPECTUS
70,549,868 Shares of Common Stock to be issued upon Exercise of Warrants
352,746 Shares of Common Stock
Title of Each Class of
Securities To Be Registered AMOUNT TO BE
REGISTERED PROPOSED
MAXIMUM OFFERING
PRICE PER UNIT Proposed Maximum
Aggregate Offering
Price Amount of
Registration Fee (2)
Common Stock, no par value, to be issued upon exercise of warrants exercisable at $0.14 per share 35,274,934 $0.14(1) $4,938,490.76 $283.57
Common Stock, no par value, to be issued upon exercise of warrants exercisable at $0.19 per share 35,274,934 $0.19(1) $6,702,237.46 $384.84
Common Stock, no par value 352,746 $0.08(1) $41,230.72 $2.38
The Company will receive cash upon the exercise of the warrants of up to $11,640,728.22.
http://www.sec.gov/Archives/edgar/data/1141788/000118811210001292/t68034a_posam.htm
"Dr. Albitar will immediately help position the Company to expand its pipeline of molecular diagnostic and medical imaging tests for cancer using the Company’s patented Support Vector Machine technology." To me this implies he will be working to develop more or other tests and not necessarily to validate the PC test that has already been developed.
What about the biscuits and sausage gravy?
TS Bob, With all due respect, I think it was Scott's intent to assure Tryn that the shareholders would not vote for an increase in A/S if there was a judgment against the company regarding note J/M. In my opinion, the last thing we want to see is an increase in A/S. WHY? Because we don't want dilution! Why would any existing shareholder want to see his or her percentage of ownership in the company reduced? I think there are sufficient shares to cover all of the outstanding warrants with the current A/S amount. If most of the warrants are exercised (which seems to be the case), the company should have plenty of working capital until the royalties kick in. If this happens, there will be no need to sell more shares and dilute the existing stockholders (I hope).
This is actually good news because it's an indication that they were able to get the warrant holders to exercise and must have taken in a good chunk of change. This does NOT indicate that it will be necessary to increase the authorized share amount.
1 Share DNDN Buys 300 HDVY (PC Pee Pee test soon)
Say bye bye to PSA.
1 Share DNDN = 315 Shares HDVY
1 Share DNDN = 277 Shares of HDVY
Which is the better value? Time will tell.
1 Share DNDN = 277 Shares of HDVY
Which is the better value? Time will tell.
King, I have just adjusted my price target to +$20 per share.
Thanks.
If DNDN can trade at +$45 a share with a $2 eps LOSS, maybe we could see +$10 on this puppy someday.
Tryn, Forgot about Bright-Lights:
http://www.mddexec.com/sales2010/speaker...
You mentioned another conference for May in your post #6214. The link for that didn't work. Please can you recycle that one. May might not be so bad after all. Thanks.
Looks like the next event will be the 10Q
on or before 5/15/10 (if nothing else happens).
Hopefully May will be better than April.
Tryn, Please advise if you connect with Scott.
Many thanks for making the effort.
Vermillion sinking below $20 probably hasen't helped.
Looks like a NYC based broker dealer:
Prime Mover Capital Partners, LP
c/o Prime Mover Capital Management, L.P., 767 Third Ave., 15th Fl.,
New York, NY 10017
Partnership — Prime Mover Capital, LLC
Looks like they acquired the position in 2010 in addition to
2.33M shares held by MicroCapital, LLC.
Did not see any of the above in the 10K. :
Here is the Yahoo Finance Listing as of 31-Dec-09
CONESTOGA CAPITAL ADVISORS, LLC 100,000
PATTEN & PATTEN, INC. 52,223
ACADEMY CAPITAL MANAGEMENT, INC. 38,910
CRAWFORD INVESTMENT COUNSEL, INC. 10,000
KO, Who is PMCP and when did they acquire 6M shares?
Please provide a link. Thanks.
I see 210.7M O/S when I quote the stock.
Did you know HDVY owns 45% of SVM Capital?
Don't forget HDC owns 20% of SPM
Dr. Richard E. Caruso Ph.D., 66
Founder and Chairman of Integra LifeSciences Holdings Corporation
(IART)
Market Cap (intraday)5: 1.27B
Enterprise Value (25-Mar-10)3: 1.59B
Trailing P/E (ttm, intraday): 25.53
Forward P/E (fye 31-Dec-11) 1: 14.82
PEG Ratio (5 yr expected): 1.04
Price/Sales (ttm): 1.87
Price/Book (mrq): 2.86
Enterprise Value/Revenue (ttm)3: 2.33
Enterprise Value/EBITDA (ttm)3: 11.039
Petition Signed & Verified,Thanks
The most important thing about the news today might be our increase of SPM equity to 20% so when it goes public and trades at $100 per share I can book another vacation here in Costa Rica, where I am currently enjoying the second of 5 days of vacation!!!
http://www.hotelparador.com/videos/hotel-video.html
http://www.hotelparador.com/videos/activities-video.html
GLTA